Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Investigating the Variability of Fluid Resuscitation during Laparoscopic Donor Nephrectomy
A. Williams,¹ S. Kumar,² R. Sung,¹ K. Woodside,¹ M. Englesbe,¹ M. Alameddine,¹ S. Waits.¹
¹Department of Surgery, Section of Transplantation, University of Michigan, Ann Arbor, MI; ²Department of Anesthesia, University of Michigan, Ann Arbor, MI.
Background: Under or over resuscitation during laparoscopic donor nephrectomy may have a significant effect on donor and graft outcomes. Despite the importance, no guidelines exist…
2018 American Transplant Congress
Psychotic Disorders and Outcomes after Kidney Transplantation
M. Molnar,^1,2 J. Eason,^1,2 A. Gaipov,³ M. Talwar,^1,2 P. Potukuchi,³ K. Kalantar-Zadeh,⁴ C. Kovesdy.^3,5
¹Division of Transplant Surgery, Methodist University Hospital Transplant Institute, Memphis, TN; ²Department of Surgery, University of Tennessee Health Science Center, Memphis, TN; ³Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN; ⁴Division of Nephrology, University of California, Irvine, CA; ⁵Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, TN.
Background: The prevalence of bipolar disorder and schizophrenia combined is around 1-4% in the general population and both represent relative contraindications for kidney transplantation. However,…
2018 American Transplant Congress
Patient and Transplant Outcome in Infants Starting Renal Replacement Therapy before Two Years of Age
J. Hogan,^1,2,3 J. Harambat,⁴ E. Berard,⁵ C. Couchoud,³ M-.A. Macher.^2,3
¹Pediatric Nephrology, Emory University, Atlanta, GA; ²Pediatric Nephrology, Robert Debre University Hospital, Paris, France; ³REIN Registry, French Biomedecine Agency, Paris, France; ⁴Pediatric Nephrology, Bordeaux University Hospital, Bordeaux, France; ⁵Pediatric Nephrology, L'archet Hospital, Nice, France.
Introduction: Despite major technical improvement in the care of children requiring renal replacement therapy (RRT) before two years of age, the management of those patients…
2018 American Transplant Congress
Age Difference between Donor and Recipient Predisposes to Early Interstitial Fibrosis and Tubular Atrophy in Pediatric Kidney Transplantation
S. Panombualert, M. Pearl, P. Weng, R. Ettenger.
Pediatric Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Introduction: Previous studies in adult kidney transplant recipients (KTRs) have shown that an increased age difference between donor and recipient increases the risk of arterial…
2018 American Transplant Congress
Is BMI > 35 a Barrier to Kidney Transplantation?
D. Walczak, E. Benedetti, C. Ryan.
Organ Transplant, University of Illinois, Chicago, IL.
Background:Although lower rates of patient and graft survival are reported for kidney transplant recipients with BMI > 35, kidney transplant in this group provides a…
2018 American Transplant Congress
Lower Incidence of De Novo Donor-Specific Antibodies against HLA-DR in ABO-Incompatible Renal Transplantation
M. Okada,¹ K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ K. Iwasaki,² T. Kobayashi.²
¹Department of Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan; ²Department of Transplant Surgery, Aichi Medical University, Nagakute, Japan.
IntroductionDe novo DSA-induced chronic antibody-mediated rejection (AMR) is one of major obstacles to long term graft survival. We have reported that anti-A/B antibody binding could…
2018 American Transplant Congress
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease
E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
NYU Langone Medical Center, New York, NY.
Objective: Peripheral vascular disease (PVD) is common among end-stage renal disease (ESRD) patients and is a known independent risk factor for increased post-transplant mortality. The…
2018 American Transplant Congress
Early Conversion to a CNI-Free Immunosuppression with SRL after Renal Tx – 10 yr Follow-Up Analysis of a Prospective Multicenter Trial
J. Andrassy,¹ M. Guba,¹ A. Habicht,² M. Fischereder,³ A. Pascher,⁴ K. Heller,⁵ B. Banas,⁶ O. Hakenberg,⁷ T. Vogel,⁸ T. Kauke.¹
¹Surgery, Ludwig-Maximilans-University, Munich, Germany; ²Transplant, Ludwig-Maximilans-University, Munich, Germany; ³Nephrology, MED IV, Ludwig-Maximilans-University, Munich, Germany; ⁴Surgery, Charitée University, Berlin, Germany; ⁵Medicine, University of Erlangen, Erlangen, Germany; ⁶Internal Medicine II, University of Regensburg, Regensburg, Germany; ⁷Urology, University of Rostock, Rostock, Germany; ⁸Surgery, University of Munster, Munster, Germany.
Introduction: A prospective multicenter trial comparing an early conversion to a CNI-free immunosuppression with SRL, MMF and steroids with a conventional CsA treatment following renal…
2018 American Transplant Congress
CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction
T. Jouve,^1,4 R. Germi,^2,4 B. Janbon,¹ G. Fiard,^3,4 P. Malvezzi,¹ L. Rostaing.^1,4
¹Nephrology, Dialysis, Apheresis, Transplantation Unit, Grenoble University Hospital, Grenoble, France; ²Virology Unit, Grenoble University Hospital, Grenoble, France; ³Urology Unit, Grenoble University Hospital, Grenoble, France; ⁴Medical Sciences, Grenoble University, Grenoble, France.
Cytomegalovirus (CMV) and BK Virus (BKV) infections are frequent complications after kidney transplantation. A combined regimen of calcineurin inhibitor (CNI) and mTOR inhibitors (mTORi) reduces…
2018 American Transplant Congress
Mycophenolate Monotherapy is Safe and Effective in HLA-Matched Kidney Transplant Recipients
A. Hennes, K. Holdener, W. Burlingham, B. Astor, A. Djamali.
UW Health, Madison, WI.
Purpose: The ideal minimizing strategy for maintenance immunosuppression in HLA-matched kidney transplant recipients (KTR) is unknown. We hypothesized that mycophenolate (MPA) monotherapy is a safe…